Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

  Email address:
   

China Releases a New National Drug Reimbursement List

publication date: Dec 2, 2009
On November 30th, China’s MoHRSS (Ministry of Human Resources and Social Security) released the 2009 version of the National Drug Reimbursement List, which includes 260 new drugs, bringing it to a total of 2151 products. In the new list, all 307 members of the Essential Drug List are automatically included in the A class, which confers the highest levels of insurance reimbursement on these basic drugs. It was the first update of the Reimbursement List since 2004. More details...


Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes


Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
November 2-3, 2023 | Shanghai
November 7-8, 2023 | Digital